000461 IS SERUM CA 125 ESSENTIAL TO DIFFERENTIATE BETWEEN MALIGNAT AND BENIGN ADNEXAL TUMOURS? A MULTICENTRE STUDY BY THE INTERNATIONAL OVARIAN TUMOUR ANALYSIS (IOTA) GROUP

D. Timmerman; B. Van Calster; D. Jurkovic; L. Valentin; A. C. Testa; J. P. Bernard; C. Van Holsbeke; S. Van Huffel; I. Vergote; T. Bourne

doi:10.1136/ijgc-00009577-200509001-00457

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Poster Group 3B – Wednesday, September 28, 2005

000461 IS SERUM CA 125 ESSENTIAL TO DIFFERENTIATE BETWEEN MALIGNAT AND BENIGN ADNEXAL TUMOURS? A MULTICENTRE STUDY BY THE INTERNATIONAL OVARIAN TUMOUR ANALYSIS (IOTA) GROUP

	Abstract	Full	Pdf
Mar 2019	0	0	1
Total	0	0	1

Main menu

Online download statistics by month:

Online download statistics by month: March 2019 to March 2019

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: March 2019 to March 2019

Read the full text or download the PDF:

Log in using your username and password